- Home
- PRE vs VTGN Comparison
PRE vs VTGN Comparison
Compare PRE & VTGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRE
- VTGN
- Stock Information
- Founded
- PRE 2014
- VTGN 1998
- Country
- PRE Hong Kong
- VTGN United States
- Employees
- PRE N/A
- VTGN N/A
- Industry
- PRE Biotechnology: Laboratory Analytical Instruments
- VTGN Biotechnology: Pharmaceutical Preparations
- Sector
- PRE Industrials
- VTGN Health Care
- Exchange
- PRE Nasdaq
- VTGN Nasdaq
- Market Cap
- PRE 69.7M
- VTGN 81.3M
- IPO Year
- PRE N/A
- VTGN N/A
- Fundamental
- Price
- PRE $5.66
- VTGN $2.92
- Analyst Decision
- PRE Buy
- VTGN
- Analyst Count
- PRE 1
- VTGN 0
- Target Price
- PRE $9.00
- VTGN N/A
- AVG Volume (30 Days)
- PRE 10.3K
- VTGN 401.9K
- Earning Date
- PRE 11-27-2024
- VTGN 02-11-2025
- Dividend Yield
- PRE N/A
- VTGN N/A
- EPS Growth
- PRE N/A
- VTGN N/A
- EPS
- PRE N/A
- VTGN N/A
- Revenue
- PRE $25,561,362.00
- VTGN $876,000.00
- Revenue This Year
- PRE $50.97
- VTGN N/A
- Revenue Next Year
- PRE $217.53
- VTGN N/A
- P/E Ratio
- PRE N/A
- VTGN N/A
- Revenue Growth
- PRE N/A
- VTGN 8.08
- 52 Week Low
- PRE $2.85
- VTGN $2.22
- 52 Week High
- PRE $7.84
- VTGN $5.74
- Technical
- Relative Strength Index (RSI)
- PRE 52.93
- VTGN 53.24
- Support Level
- PRE $5.27
- VTGN $2.40
- Resistance Level
- PRE $6.00
- VTGN $3.40
- Average True Range (ATR)
- PRE 0.27
- VTGN 0.21
- MACD
- PRE -0.02
- VTGN -0.00
- Stochastic Oscillator
- PRE 55.83
- VTGN 47.83
About PRE Prenetics Global Limited
Prenetics Global Ltd is a health sciences company dedicated to consumer and clinical health. Its consumer initiative is led by IM8, a new health and wellness brand, and Europa, a U.S. sports distribution company. The clinical division is led by Insighta, focused on multi-cancer early detection technologies. This is followed by ACT Genomics, which has achieved FDA clearance for genomic profiling of solid tumors, and CircleDNA, which uses NGS to offer DNA tests. Each Prenetics unit impacts health by 'enhancing life through science'.
About VTGN VistaGen Therapeutics Inc.
Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on deep understanding of nose-to-brain neurocircuitry.